n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jajoo, S; Mukherjea, D; Ramkumar, V; Watabe, K | 1 |
Aghaei, M; Karami-Tehrani, F; Panjehpour, M; Salami, S | 1 |
2 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Cancer of Prostate
Article | Year |
---|---|
Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.
Topics: Adenosine; Animals; Blotting, Western; Cell Line, Tumor; Cell Movement; Cyclic AMP-Dependent Protein Kinases; Humans; Immunohistochemistry; Male; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidases; Neoplasm Invasiveness; Prostatic Neoplasms; Rats; Receptor, Adenosine A3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transfection; Xenograft Model Antitumor Assays | 2009 |
Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.
Topics: Adenosine; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; G1 Phase; Humans; Male; Membrane Potential, Mitochondrial; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptor, Adenosine A3; Tumor Suppressor Protein p53 | 2011 |